Target intelligence / Profile preview

Ultrasound Contrast Agent (UCA)

Target: UCA
Molecular classification: Contrast Agent

Overview

Ultrasound contrast agents are gas-filled microbubbles stabilized by a biocompatible shell, used to enhance the visibility of blood vessels, tissues, and organs during ultrasound examinations. They remain strictly intravascular and vibrate under ultrasound waves, producing strong echoes.

Other names: MicrobubblesEchocardiography contrastSonographic contrast agent

Mechanism of action

Enhances echogenicity by oscillating under ultrasound waves, producing strong echoes.

Biological functions

Enhancement of ultrasound imagingVisualization of blood flowVisualization of tissue perfusion

Disease associations

Cardiovascular diseaseLiver diseaseCancer (imaging)Other

Safety considerations

Allergic reactionsArrhythmias (rare, in susceptible patients)Bubble rupture at high acoustic pressures

Beyond the preview

Go deeper on Ultrasound Contrast Agent (UCA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ultrasound Contrast Agent (UCA).

Explore the full profile